
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
IL-1ra CRISPR/Cas9 KO Plasmid (h) | sc-401313 | 20 µg | $397.00 |
Human IL1RN encodes interleukin-1 receptor antagonist (IL-1ra), a secreted regulator that competitively inhibits IL-1α and IL-1β binding to IL-1 receptor type I, thereby attenuating downstream MyD88-dependent signaling. By restraining IL-1–driven activation of NF-κB and MAPK pathways, IL-1ra modulates transcriptional programs controlling cytokine production, leukocyte recruitment, and acute-phase inflammatory responses. Dysregulated IL1RN activity is linked to aberrant innate immune signaling and altered inflammatory set points, making it relevant to studies of autoinflammation, arthritis-associated pathways, and broader cytokine network regulation. IL1RN is also used as a marker node for interrogating inflammasome-IL-1 axis dynamics and feedback control in macrophages, epithelial cells, and stromal compartments.
IL-1ra CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the IL1RN gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the IL1RN together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the IL1RN open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish IL-1ra protein expression.
This CRISPR knockout system enables efficient generation of IL1RN-deficient cell models for investigation of IL-1ra signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.